Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas B La Thangue

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Nature Cell Biology|February 4, 2005
A mismatched role for Bcl-2Nicholas B La Thangue
Science (New York, N.Y.)|May 11, 2002
Transcription. Chromatin control--a place for E2F and Myc to meetNicholas B La Thangue
Nature Cell Biology|July 2, 2003
The yin and yang of E2F-1: balancing life and deathNicholas B La Thangue
Immunology and Cell Biology|November 30, 2011
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applicationsOmar Khan, Nicholas B La Thangue
Molecular & Cellular Oncology|December 7, 2017
Linking H1 with chromatin and growth controlShonagh Munro, Nicholas B La Thangue
Cell Cycle (Georgetown, Tex.)|September 10, 2003
A new role for E2F-1 in checkpoint controlCraig Stevens, Nicholas B La Thangue
DNA Repair|July 29, 2004
The emerging role of E2F-1 in the DNA damage response and checkpoint controlCraig Stevens, Nicholas B La Thangue
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Signalling DNA damage by regulating p53 co-factor activityLinda Smith, Nicholas B La Thangue
Nature Clinical Practice. Oncology|October 8, 2008
Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomasOmar Khan, Nicholas B La Thangue
Progress in Cell Cycle Research|November 5, 2003
Drug discovery and the p53 familyConstantinos Demonacos, Nicholas B La Thangue
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Nature Cell Biology|February 4, 2005
A mismatched role for Bcl-2Nicholas B La Thangue
Science (New York, N.Y.)|May 11, 2002
Transcription. Chromatin control--a place for E2F and Myc to meetNicholas B La Thangue
Nature Cell Biology|July 2, 2003
The yin and yang of E2F-1: balancing life and deathNicholas B La Thangue
Immunology and Cell Biology|November 30, 2011
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applicationsOmar Khan, Nicholas B La Thangue
Molecular & Cellular Oncology|December 7, 2017
Linking H1 with chromatin and growth controlShonagh Munro, Nicholas B La Thangue
Cell Cycle (Georgetown, Tex.)|September 10, 2003
A new role for E2F-1 in checkpoint controlCraig Stevens, Nicholas B La Thangue
DNA Repair|July 29, 2004
The emerging role of E2F-1 in the DNA damage response and checkpoint controlCraig Stevens, Nicholas B La Thangue
Cell Cycle (Georgetown, Tex.)|January 19, 2005
Signalling DNA damage by regulating p53 co-factor activityLinda Smith, Nicholas B La Thangue
Nature Clinical Practice. Oncology|October 8, 2008
Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomasOmar Khan, Nicholas B La Thangue
Progress in Cell Cycle Research|November 5, 2003
Drug discovery and the p53 familyConstantinos Demonacos, Nicholas B La Thangue
Pageof 8